Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece

Simple item page
dc.contributor.authorDalekos, G. N.en
dc.contributor.authorZervou, E.en
dc.contributor.authorKarabini, F.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorBourantas, K.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T18:56:53Z
dc.date.available2015-11-24T18:56:53Z
dc.identifier.issn0041-1132-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19106
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subject*Blood Donorsen
dc.subjectBlood Transfusionen
dc.subjectDeltaretrovirus Antibodies/*immunologyen
dc.subjectFemaleen
dc.subjectGreeceen
dc.subjectHTLV-I Infections/*epidemiologyen
dc.subjectHTLV-II Infections/*epidemiologyen
dc.subjectHuman T-lymphotropic virus 1/*immunologyen
dc.subjectHuman T-lymphotropic virus 2/*immunologyen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectSubstance-Related Disorders/microbiologyen
dc.titlePrevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greeceen
heal.abstractBACKGROUND: In addition to human immunodeficiency virus, human T-lymphotropic virus types I and II (HTLV-I/II) is prevalent among blood donors in the United States. In Greece, there are no epidemiologic data regarding the prevalence of HTLV-I/II among volunteer blood donors and high-risk groups. STUDY DESIGN AND METHODS: To determine the prevalence of HTLV-I/II infections in northwestern Greece, a seroepidemiologic study was conducted among volunteer blood donors, multiply transfused patients, heroin addicts, and chronic hemodialysis patients. The subjects were tested for serologic evidence of HTLV-I/II infection by enzyme immunoassays and specific protein immunoblot confirmatory test. RESULTS: None of the volunteer blood donors and heroin addicts had detectable antibodies to HTLV-I/II. Only 1 (1.45%) of the 69 multiply transfused patients had indeterminate results, while 2 (1.2%) of 163 hemodialysis patients were positive. CONCLUSION: In northwestern Greece, routine screening for HTLV-I and HTLV-II infections does not appear to be required. However, the finding of seropositivity among hemodialysis patients requires further evaluation of the origin of the infection, as its zero prevalence in this population seems to exclude transfusion transmission.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/7770902-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1046/j.1537-2995.1995.35695288770.x/asset/j.1537-2995.1995.35695288770.x.pdf?v=1&t=h0njt0u3&s=1cc2ce429ab8f367352f7c16b76c4acfaebe6dad-
heal.journalNameTransfusionen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1995-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ